financetom
Business
financetom
/
Business
/
HDFC Bank acquires 7.4% stake in Virtuoso Infotech
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
HDFC Bank acquires 7.4% stake in Virtuoso Infotech
Jun 28, 2021 2:08 AM

Virtuoso Infotech Pvt. Ltd., an enterprise software solutions company, founded by Ms Preeti Nahar and Mr Yogesh Satpute, based out of Pune, India announced today the news of its first investment fundraise. India's largest private sector bank HDFC and its subsidiary HDFC Securities Limited has acquired a 7.4 percent stake in Virtuoso Infotech.

Share Market Live

NSE

Virtuoso Infotech specialises in product engineering and offers customised software solutions for enterprises across a wide range of sectors. The list includes software solutions for Hospitality, Finance, Media, Religious Institutions, Communities, Cloud Computing, Food and Travel industries, using Data Analytics and Machine Learning.

This relationship will strengthen the company's vision to become a reliable software technology partner for Indian Enterprises and the bank's objective to digitise under-served and under-penetrated segments using digital solutions.

“We thank HDFC Bank for their confidence and trust in Virtuoso's tech capabilities”, said Ms Preeti Nahar, CEO, Virtuoso Infotech. “We are excited to start our growth journey with HDFC Bank and HDFC securities, serving the diversified needs of banking and securities business.”

"We are looking forward to contribute and make a dent in digital universe with our joint capabilities. Bank has always been supporting companies that help them take digitization to the next level”, said Mr Yogesh Satpute, CTO, Virtuoso Infotech.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
PharmaTher's Sairiyo Therapeutics Gets OK to Initiate a Phase 1 Human Clinical Trial of PD-001 (Reformulated Cepharanthine)
PharmaTher's Sairiyo Therapeutics Gets OK to Initiate a Phase 1 Human Clinical Trial of PD-001 (Reformulated Cepharanthine)
Aug 19, 2024
08:04 AM EDT, 08/19/2024 (MT Newswires) -- PharmaTher Holdings Ltd. ( PHRRF ) , a specialty pharmaceutical company, announced Monday Sairiyo Therapeutics Inc., a company that is 49% owned by PharmaTher ( PHRRF ) and 51% owned by PharmaDrug Inc. ( LMLLF ) , has received approval by the Australian Human Research Ethics Committee to initiate a first-in-human Phase 1...
Tonix Pharmaceuticals Holding's Q2 Loss Narrows, Revenue Rises
Tonix Pharmaceuticals Holding's Q2 Loss Narrows, Revenue Rises
Aug 19, 2024
08:01 AM EDT, 08/19/2024 (MT Newswires) -- Tonix Pharmaceuticals Holding ( TNXP ) reported a Q2 loss Monday of $19.28 per diluted share, narrowing from a loss of $49.23 a year earlier. Three analysts polled by Capital IQ expected a loss of $3.27. Revenue for the quarter ended June 30 was $2.21 million, compared with no revenue a year earlier....
Laramide Resources Says Australian Drilling Proceeding as Planned
Laramide Resources Says Australian Drilling Proceeding as Planned
Aug 19, 2024
08:05 AM EDT, 08/19/2024 (MT Newswires) -- Laramide Resources ( LMRXF ) , a uranium mine development and exploration company with assets in the United States and Australia, on Monday provided an update on its drilling activities at the Westmoreland Uranium Project in Queensland, Australia. This season's exploration drilling campaign is comprised of up to 12,000 metres of diamond and...
Tiziana Life Sciences Names Ivor Elrifi as CEO
Tiziana Life Sciences Names Ivor Elrifi as CEO
Aug 19, 2024
08:05 AM EDT, 08/19/2024 (MT Newswires) -- Tiziana Life Sciences ( TLSA ) said Monday it has named Ivor Elrifi as chief executive officer, effective immediately. He succeeds Gabriele Cerrone, who served as chief executive and will remain as executive chairman of the board. Elrifi previously served as global head of the patent group at Cooley and global head of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved